Long‐lasting target binding and rebinding as mechanisms to prolong in vivo drug action
- 3 September 2010
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 161 (3), 488-508
- https://doi.org/10.1111/j.1476-5381.2010.00936.x
Abstract
An increasing number of examples in the literature suggest that the in vivo duration of drug action not only depends on macroscopic pharmacokinetic properties like plasma half-life and the time needed to equilibrate between the plasma and the effect compartments, but is also influenced by long-lasting target binding and rebinding. The present review combines information from different research areas and simulations to explore the nature of these mechanisms and the conditions in which they are most prevalent. Simulations reveal that these latter phenomena become especially influential when there is no longer sufficient free drug around to maintain high levels of receptor occupancy. There is not always a direct link between slow dissociation and long-lasting in vivo target protection, as the rate of free drug elimination from the effect compartment is also a key influencing factor. Local phenomena that hinder the diffusion of free drug molecules away from their target may allow them to consecutively bind to the same target and/or targets nearby (denoted as 'rebinding') even when their concentration in the bulk phase has already dropped to insignificant levels. The micro-anatomic properties of many effect compartments are likely to intensify this phenomenon. By mimicking the complexity of tissues, intact cells offer the opportunity to investigate both mechanisms under the same, physiologically relevant conditions.Keywords
This publication has 139 references indexed in Scilit:
- On the mechanism of the persistent action of salmeterol: what is the current position?British Journal of Pharmacology, 2009
- Molecular mechanisms for the persistent bronchodilatory effect of the β2‐adrenoceptor agonist salmeterolBritish Journal of Pharmacology, 2009
- Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptorBritish Journal of Pharmacology, 2007
- Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal conceptsThe AAPS Journal, 2007
- For catch bonds, it all hinges on the interdomain regionThe Journal of cell biology, 2006
- Flow-enhanced adhesion regulated by a selectin interdomain hingeThe Journal of cell biology, 2006
- Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3receptorBritish Journal of Pharmacology, 2006
- Structure and Dynamics of Micelle-bound Neuropeptide Y: Comparison with Unligated NPY and Implications for Receptor SelectionJournal of Molecular Biology, 2001
- The Immunological Synapse: A Molecular Machine Controlling T Cell ActivationScience, 1999
- Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's diseaseJournal of Neural Transmission, 1993